GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » Cash Flow from Financing

Danimer Scientific (Danimer Scientific) Cash Flow from Financing : $84.03 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, Danimer Scientific paid $0.00 Mil more to buy back shares than it received from issuing new shares. It spent $0.59 Mil paying down its debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.14 Mil on other financial activities. In all, Danimer Scientific spent $0.46 Mil on financial activities for the three months ended in Dec. 2023.


Danimer Scientific Cash Flow from Financing Historical Data

The historical data trend for Danimer Scientific's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific Cash Flow from Financing Chart

Danimer Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
53.50 422.68 306.20 21.75 84.03

Danimer Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 91.54 -6.51 -0.54 -0.46

Danimer Scientific Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Danimer Scientific's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Danimer Scientific's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $84.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danimer Scientific  (NYSE:DNMR) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Danimer Scientific's issuance of stock for the three months ended in Dec. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Danimer Scientific's repurchase of stock for the three months ended in Dec. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Danimer Scientific's net issuance of debt for the three months ended in Dec. 2023 was $-0.59 Mil. Danimer Scientific spent $0.59 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Danimer Scientific's net issuance of preferred for the three months ended in Dec. 2023 was $0.00 Mil. Danimer Scientific paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Danimer Scientific's cash flow for dividends for the three months ended in Dec. 2023 was $0.00 Mil. Danimer Scientific received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Danimer Scientific's other financing for the three months ended in Dec. 2023 was $0.14 Mil. Danimer Scientific received $0.14 Mil on other financial activities.


Danimer Scientific Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Danimer Scientific (Danimer Scientific) Business Description

Traded in Other Exchanges
Address
140 Industrial Boulevard, Bainbridge, GA, USA, 39817
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Executives
Richard J Hendrix director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten officer: Chief Marketing Officer 286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt director 730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen director 1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian director
Michael A Hajost officer: Chief Financial Officer C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey director, officer: CEO & Chairman of the Board C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt director 303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D officer: Chief Technology Officer 1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun director 2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda director 1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith officer: Chief Operating Officer 2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco director 206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr 10 percent owner, officer: President, other: President CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367